CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $33,000 | -38.9% | 22,900 | -8.0% | 0.04% | -32.2% |
| Q2 2022 | $54,000 | -75.2% | 24,900 | -63.6% | 0.06% | -65.1% |
| Q1 2022 | $218,000 | -68.9% | 68,400 | -20.6% | 0.17% | -67.1% |
| Q3 2021 | $701,000 | -32.3% | 86,200 | -37.0% | 0.51% | -33.9% |
| Q2 2021 | $1,035,000 | -14.0% | 136,900 | -1.6% | 0.78% | -13.9% |
| Q1 2021 | $1,204,000 | -99.9% | 139,100 | 0.0% | 0.90% | +0.9% |
| Q4 2020 | $1,111,127,000 | -2.8% | 139,100 | -51.4% | 0.89% | -8.3% |
| Q3 2020 | $1,142,990,000 | +204370.5% | 286,200 | +406.5% | 0.97% | +82.7% |
| Q2 2020 | $559,000 | +107.8% | 56,500 | +61.4% | 0.53% | +102.7% |
| Q1 2020 | $269,000 | +133.9% | 35,000 | +16.7% | 0.26% | +260.3% |
| Q4 2019 | $115,000 | – | 30,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |